Medicare Enrolled
Dr. Edward Oruci, M.D.
Optician · Roslyn, NY
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oruci from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oruci?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oruci
Dr. Edward Oruci is an optician specialist in Roslyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Oruci performed 5,872 Medicare services across 3,675 unique beneficiaries.
Between the years covered by Open Payments, Dr. Oruci received a total of $14,795 from 43 pharmaceutical and/or device companies across 682 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oruci is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NY
$14,795 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,872
Medicare services
Top 12% in NY for optician
3,675
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~294 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,763 | $13 | $52 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,742 | $114 | $442 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
705 | $162 | $691 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
549 | $73 | $270 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
303 | $183 | $689 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
103 | $12 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
103 | $157 | $579 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
90 | $58 | $246 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
86 | $64 | $259 |
| Cardiac catheterization | 72 | $251 | $1,053 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
63 | $122 | $447 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
60 | $48 | $178 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
60 | $23 | $84 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
60 | $199 | $817 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
37 | $520 | $2,159 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
34 | $83 | $313 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $81 | $313 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $367 | $1,338 |
| Aortography with contrast and radiologist review An imaging procedure using contrast dye to visualize the aorta above the heart valve, including professional review by a radiologist. |
11 | $39 | $142 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.9% high complexity
8.7% medium
76.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,795
Total received (2018-2024)
Avg $2,114/year across 7 years
Top 10% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
682
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,795 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,362
2023
$1,987
2022
$2,983
2021
$2,515
2020
$1,686
2019
$1,925
2018
$1,338
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$273
E.R. Squibb & Sons, L.L.C.
$226
Amgen Inc.
$209
PFIZER INC.
$180
Daiichi Sankyo Inc.
$168
AstraZeneca Pharmaceuticals LP
$143
Lexicon Pharmaceuticals, Inc.
$140
Novo Nordisk Inc
$134
SANOFI-AVENTIS U.S. LLC
$117
Medtronic, Inc.
$117
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
Merck Sharp & Dohme LLC
$97
Esperion Therapeutics, Inc.
$87
Boston Scientific Corporation
$80
HEARTFLOW, INC.
$53
Janssen Pharmaceuticals, Inc
$41
Chiesi USA, Inc.
$36
CVRx, Inc.
$28
Regeneron Healthcare Solutions, Inc.
$25
Inspire Medical Systems, Inc.
$23
Kiniksa Pharmaceuticals International, plc
$22
Abbott Laboratories
$21
Cumberland Pharmaceuticals, Inc.
$19
SCPHARMACEUTICALS INC.
$15
Top 3 companies account for 30.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,626
Novartis Pharmaceuticals Corporation
$1,296
AstraZeneca Pharmaceuticals LP
$1,256
Janssen Pharmaceuticals, Inc
$1,003
Boehringer Ingelheim Pharmaceuticals, Inc.
$918
Medtronic, Inc.
$851
Medtronic Vascular, Inc.
$775
PFIZER INC.
$727
E.R. Squibb & Sons, L.L.C.
$706
Esperion Therapeutics, Inc.
$606
Abbott Laboratories
$539
Merck Sharp & Dohme LLC
$528
Bayer HealthCare Pharmaceuticals Inc.
$453
Novo Nordisk Inc
$406
SANOFI-AVENTIS U.S. LLC
$381
Chiesi USA, Inc.
$331
Boston Scientific Corporation
$228
Lexicon Pharmaceuticals, Inc.
$227
NOVARTIS PHARMACEUTICALS CORPORATION
$224
ARBOR PHARMACEUTICALS, INC.
$219
Althera Pharmaceuticals LLC
$195
Daiichi Sankyo Inc.
$168
Kowa Pharmaceuticals America, Inc.
$134
Regeneron Healthcare Solutions, Inc.
$114
Kestra Medical Technology Services, Inc.
$109
Merck Sharp & Dohme Corporation
$107
Kiniksa Pharmaceuticals, Ltd.
$55
HEARTFLOW, INC.
$53
CHIESI USA, INC.
$52
Astellas Pharma US Inc
$52
Lundbeck LLC
$47
CSL Behring
$45
Inspire Medical Systems, Inc.
$42
Impulse Dynamics (USA) Inc.
$41
Gilead Sciences, Inc.
$41
Allergan Inc.
$40
SCPHARMACEUTICALS INC.
$40
Relypsa, Inc.
$38
Cumberland Pharmaceuticals, Inc.
$36
CVRx, Inc.
$28
Kiniksa Pharmaceuticals International, plc
$22
Arbor Pharmaceuticals, Inc.
$21
BOSTON SCIENTIFIC CORPORATION
$16
Top 3 companies account for 28.2% of all-time payments
Associated products mentioned in payments ›
AVEIR · Arcalyst · Assure WCD · BRILINTA · BYDUREON · BYSTOLIC · Barostim Neo System · CALDOLOR · CAMZYOS · CHANTIX · CLEVIPREX · CardioMEMS HF System · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FFRct · FUROSCIX · GALLANT · INJECTAFER · INSPIRE · Inpefa · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · Kcentra · Kerendia · LEQVIO · LEXISCAN · LIVALO · LOKELMA · Livalo · MITRACLIP · MOSAIC · MULTAQ · Mitra Clip system · Mosaic · NEXLETOL · NEXLIZET · NORTHERA · ONYX FRONTIER · OPTIS · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · Ranexa · Repatha · Resolute · Roszet · Rybelsus · VERQUVO · VYNDAQEL · Veltassa · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for optician in NY.
Geographic Context
Opticians within 10 mi
16,372
Per 100K population
1179.4
County median income
$143,408
Nearest hospital
ST FRANCIS HOSPITAL - THE HEART CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oruci is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 12% in NY), with low-engagement industry engagement in the top 10% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oruci experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Oruci performed 1,763 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oruci receive payments from pharmaceutical companies?
Yes. Dr. Oruci received a total of $14,795 from 43 companies across 682 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oruci's costs compare to other opticians in Roslyn?
Dr. Oruci's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oruci) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Roslyn
Browse opticians in Roslyn ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology